MEGAN GOULARD: Open Payments
NPI 1215342662 · FOXBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 31 payments from 13 companies in 2025. Trend: 2023 $881 · 2024 $827 · 2025 $866
Food & beverage: $856Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $214 |
| LEO Pharma Inc. | 5 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $108 |
| Incyte Corporation | 5 | $105 |
| Amgen Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Janssen Biotech, Inc. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| UCB, Inc. | 1 | $23 |
| Organon LLC | 1 | $22 |
Products named: SKYRIZI, ADBRY, ILUMYA, OPZELURA, Otezla, TREMFYA, DUPIXENT, Bimzelx.
Industry payments across MA — which companies pay providers there.
